Abbott’s Everyday Products Dominate Danaher’s Biotech Gear Market
Abbott Laboratories posted a stronger quarter driven by consumer-facing devices and diagnostics, while Danaher faced ...
If you need cash right now, there are several ways to obtain it quickly. Learn about options available to secure immediate funds.
24,959 articlesAbbott Laboratories posted a stronger quarter driven by consumer-facing devices and diagnostics, while Danaher faced ...
A director’s stock sale can spark worry, but not every insider move is a warning. This guide shows how to assess trad...
A modest Tuesday gain for SPGI helped the stock beat the broad market's small rise. This piece explains what a global...
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
A debt-free battery metals explorer with a large deep-sea resource aims for 2027 production, as regulators weigh perm...
AVAV is set to report Q3 results after the close. Analysts expect revenue around $203 million and non-GAAP EPS near $...
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
Millrose Properties marks its first year as an independent REIT with solid Q1 2026 earnings, expanding its builder ne...
A hedge fund with a high-conviction AI thesis is pushing a mid-cap stock higher, shedding light on how big bets in ar...
As 2026 unfolds, Tesla and BYD are diverging on growth bets. This article weighs earnings, margins, and software stra...
Zscaler is set to report Q3 after the close on May 28, 2026, with analysts eyeing ARR growth, AI monetization progres...
Investors are weighing Micron's AI-driven demand against a volatile memory market. This guide breaks down whether you...